
Science Resources RSS Feeds
|
 |
 |
 |
New Drugs Current Events | New Drugs News | 4
|
| Page
4 of
23 |
455 Results |
|
|
|
Sort By:
Page Views | Date |
Pinhead-size worms + robot = new antibiotics In an advance that could help ease the antibiotic drought, scientists in Massachusetts are describing successful use of a test that enlists pinhead-sized worms in efforts to discover badly needed new antibiotics. view more (2009-08-06)
Cell skeleton may hold key to overcoming drug resistance in cancer Researchers have uncovered a new way in which a cell protein protects cancer cells from a wide range of chemotherapeutic drugs, identifying a possible target for improving treatment outcomes for patients. view more (2007-10-04)
1 in 100 11-year-olds use drugs to enhance performance in sport More than one per cent of eleven year olds admit using performance enhancing drugs to do better in sports reports a study published online ahead of print in the British Journal of Sports Medicine. view more (2007-06-20)
Action needed to tackle fake drugs trade The World Health Organisation estimates that fake drugs account for 10% of global pharmaceutical commerce. Researchers in this week’s BMJ call for urgent international action to tackle this murderous trade. Recent examples of fake drugs include neomycin eye drops and meningococcal vaccine made of tap water; paracetamol syrup made of... view more... (2002-04-03)
Excessive use of 'reliever' inhalers linked to increased risk of death from asthma Excessive use of 'reliever' inhalers for asthma is linked to a significantly increased risk of dying from the disease, finds research in Thorax. The researchers based their findings on over 96,000 patients diagnosed with asthma whose details had been entered anonymously onto the General Practice Research Database between 1994 and 1998. They... view more... (2002-07-30)
Drug eluting nanostructured coatings enable targeted drug therapy for orthopedic patients Drug delivery systems have progressed from the teaspoon to time-release capsules to drug-eluting stents. Nanotechnology promises yet another advance by delivering therapeutic agents at desired rates exactly where needed in the body. view more (2007-05-21)
Unique new scoring system can predict risk of death from cardiovascular disease A unique new scoring system for assessing a patient's risk of death from cardiovascular disease is revealed in this week's BMJ. The score will help physicians determine a patient's need for drugs to reduce blood pressure (antihypertensive drugs) and other strategies for improving cardiovascular health. The score is based on information from eight... view more... (2001-07-11)
Athletes on performance enhancers more likely to abuse alcohol, other drugs College athletes who use performance-enhancing substances may be at heightened risk of misusing alcohol and using recreational drugs as well, according to new research in the Journal of Studies on Alcohol and Drugs. view more (2009-11-12)
Researchers explore long-term adolescent vulnerability to drugs As part of efforts to understand drug abuse, Georgia State University researchers are finding that adolescent rats appear to be less vulnerable to the long-term effects of withdrawal and relapse in certain types of drug use than rats that take the drugs in adulthood. view more (2009-09-17)
New findings show additional similarity between opiate and nicotine addiction "That was good!" "Do it again." This is what the brain says when people use tobacco, as well as 'hard drugs' such as heroin. view more (2008-02-13)
Anti-malarials most effective in lupus patients genetically at risk of high levels of TNF-alpha Anti-malarial drugs are most effective in people with lupus who are genetically predisposed to high levels of tumour necrosis factor alpha and low levels of the cytokine IL-10. view more (2006-02-13)
Diabetes targets will be impractical in routine practice Targets due to be set as part of the national service framework for diabetes in England and Wales will be impractical for use in routine clinical care, according to an article in this week’s BMJ. view more (2002-06-26)
Synthetic molecules hold promise for new family of anti-cancer drugs Synthetic molecules designed by two Hebrew University of Jerusalem researchers have succeeded in reducing and even eliminating the growth of human malignant tissues in mice, while having no toxic effects on normal tissue. view more (2008-06-05)
DOES TREATING HIGH BLOOD PRESSURE SAVE LIVES? (P1305) Findings of a meta-analysis published in this week's issue of The Lancet emphasise that blood pressure control is important and that on average, all antihypertensive drugs have similar long-term efficacy and safety. One of the most common causes of death in the developed world is cardiovascular disease (heart attacks and strokes). Measures to... view more... (2001-10-17)
HIV drugs, Abacavir and Didanosine, increase the risk of heart attack A study to assess the adverse effects of anti-retroviral drugs shows that two of the widely used HIV drugs are associated with an increased risk of heart attack/the formation of blood clots in the heart. With the use of Didanosine; the risk of developing a heart attack increases by 49%, with Abacavir; the increased risk is 90%. view more (2008-02-11)
New Paper from Internists Calls for Increased Role for FDA A new policy paper that calls for broader authority and increased funding for the Food and Drug Administration (FDA) was released today by the American College of Physicians (ACP). Improving FDA Regulation of Prescription Drugs offers a half-dozen recommendations about how to improve the agency's ability to approve and monitor new drugs. view more (2009-09-25)
Anti-psychotic drugs could help fight cancer The observation that people taking medication for schizophrenia have lower cancer rates than other people has prompted new research revealing that anti-psychotic drugs could help treat some major cancers. view more (2009-08-12)
Revolutionary new medical treatments: International effort to steer around obstacles Major developments in biotech, genomics and stem cell research now offer exciting and far-reaching new opportunities for health care in conditions ranging from Alzheimer's and Parkinson's disease to genetic disorders. However the very pharmaceutical companies who could otherwise be expected to bring the relevant treatments to the market place are... view more... (2005-01-21)
Patients resistant to blood pressure treatment do take their drugs Poor compliance with treatment is believed to be the most frequent reason why many patients with high blood pressure (hypertension) do not respond to drug treatment. However, a study in this week's BMJ finds no difference in compliance between treatment resistant and treatment responsive patients. Researchers at the University Hospital in Basle,... view more... (2001-07-18)
New method for examining cost-effectiveness of new drugs for chronic illnesses In a comprehensive analysis and mathematical model of the available scientific data, researchers at the University of York on behalf of the National Institute of Health and Clinical Excellence (NICE) in the United Kingdom found that newer drugs used to treat the most common forms of epilepsy are more expensive than older drugs, but produce similar... view more... (2005-12-30)
| |
| Page
4 of
23 |
455 Results |
|
|
|
Sort By:
Page Views | Date |
|
|